Exploring insulin analogue safety and effectiveness in a Maghrebian cohort with type 2 diabetes: results from the A₁chieve study (Q38900806)

7 September 2017

Exploring insulin analogue safety and effectiveness in a Maghrebian cohort with type 2 diabetes: results from the A₁chieve study (English)

1 reference

7 September 2017

1 reference

Mohamed Belhadj

1

1 reference

7 September 2017

Amine Dahaoui

series ordinal

2

1 reference

7 September 2017

Henda Jamoussi

series ordinal

3

1 reference

7 September 2017

Ahmed Farouqi

series ordinal

4

1 reference

7 September 2017

1 August 2013

1 reference

Diabetes Research and Clinical Practice

7 September 2017

1 reference

7 September 2017

101 Suppl 1

1 reference

7 September 2017

S4-14

1 reference

Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study

7 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2813%2970014-7

7 January 2021

Barriers to insulin injection therapy: patient and health care provider perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2813%2970014-7

7 January 2021

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2813%2970014-7

7 January 2021

The IMPROVE study--a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2813%2970014-7

7 January 2021

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2813%2970014-7

7 January 2021

Childhood obesity and the metabolic syndrome in developing countries.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2813%2970014-7

7 January 2021

Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2813%2970014-7

7 January 2021

Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2813%2970014-7

7 January 2021

Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE observational study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2813%2970014-7

7 January 2021

Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICT

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2813%2970014-7

7 January 2021

An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: the A1chieve study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2813%2970014-7

7 January 2021

Switching from biphasic human insulin 30 to biphasic insulin aspart 30 in type 2 diabetes is associated with improved glycaemic control and a positive safety profile: results from the A₁chieve study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2813%2970014-7

7 January 2021

A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2813%2970014-7

7 January 2021

Quality of life and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2813%2970014-7

7 January 2021

10.1016/S0168-8227(13)70014-7

Identifiers

DOI

1 reference

7 September 2017

1 reference